Much effort has been devoted over the past decade in extensively highlighting the tumorigenic properties of AnxA6 in several cancer types [33,37], as well as in the resistance of TNBC to EGFR-TKIs [28,32,34,35,38]. This evidence concerns the gene ANXA6 and cancer.